SNES Stock Overview
Develops a technology for managing animal pest populations through fertility control.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
SenesTech, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.80 |
| 52 Week High | US$16.68 |
| 52 Week Low | US$0.52 |
| Beta | 0.69 |
| 1 Month Change | 7.63% |
| 3 Month Change | -13.21% |
| 1 Year Change | -95.17% |
| 3 Year Change | -99.79% |
| 5 Year Change | -99.99% |
| Change since IPO | -100.00% |
Recent News & Updates
Shareholder Returns
| SNES | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 19.6% | 0.5% | -0.2% |
| 1Y | -95.2% | 17.9% | 28.2% |
Return vs Industry: SNES underperformed the US Pharmaceuticals industry which returned 16.7% over the past year.
Return vs Market: SNES underperformed the US Market which returned 27.7% over the past year.
Price Volatility
| SNES volatility | |
|---|---|
| SNES Average Weekly Movement | 12.6% |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 16.0% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: SNES's share price has been volatile over the past 3 months.
Volatility Over Time: SNES's weekly volatility has decreased from 24% to 13% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 25 | Joel Fruendt | www.senestech.com |
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
SenesTech, Inc. Fundamentals Summary
| SNES fundamental statistics | |
|---|---|
| Market cap | US$3.81m |
| Earnings (TTM) | -US$7.50m |
| Revenue (TTM) | US$1.38m |
3.0x
P/S Ratio-0.5x
P/E RatioIs SNES overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SNES income statement (TTM) | |
|---|---|
| Revenue | US$1.38m |
| Cost of Revenue | US$793.00k |
| Gross Profit | US$582.00k |
| Other Expenses | US$8.09m |
| Earnings | -US$7.50m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.46 |
| Gross Margin | 42.33% |
| Net Profit Margin | -545.82% |
| Debt/Equity Ratio | 3.9% |
How did SNES perform over the long term?
See historical performance and comparison